(Q40462711)

English

Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.

scientific article published on December 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

experimental autoimmune encephalomyelitis

1 reference

based on heuristic

inferred from title

author name string

Hideki Kato

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Atsushi Ito

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jun Kawanokuchi

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Shijie Jin

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Tetsuya Mizuno

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Kosei Ojika

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Ryuzou Ueda

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Akio Suzumura

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

651-659

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Microglia in diseases of the central nervous system

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Microglia as mediators of inflammatory and degenerative diseases

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Role of nitric oxide in inflammation-mediated neurodegeneration.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Effects of interferon-beta on microglial functions as inflammatory and antigen presenting cells in the central nervous system

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: an experimental immunomodulatory therapy

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Pituitary adenylate cyclase‐activating polypeptide inhibits cutaneous immune function

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Transfer of severe experimental autoimmune encephalomyelitis by IL-12- and IL-18-potentiated T cells is estrogen sensitive

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1096OA

21 January 2018

Identifiers

10.1191/1352458504MS1096OA

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40462711&oldid=1628929398"